CANCER GENOMICS CONSORTIUM

EIN: 273232063 501(c)(3) Medical Research

FLETCHER, NC

Total Revenue
$511,818
Total Expenses
$498,411
Total Assets
$571,996
Net Assets
$487,274
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2010
Legal Domicile
LA
Phone
6087722963
Tax Period
2025-01-01 to 2025-12-31

CANCER GENOMICS CONSORTIUM, founded in 2010, is a small nonprofit in the Medical Research sector that reported $512K in total revenue in fiscal year 2025. Revenue grew 17% year-over-year, indicating healthy expansion.

Mission

THE CANCER GENOMICS CONSORTIUM (CGC) IS COMMITTED TO PROVIDING HIGH QUALITY EDUCATION AND PROMOTING BEST LABORATORY PRACTICES IN CLINICAL CANCER GENOMICS.

Program Service Accomplishments

Program 1
Expenses: $347,048

ANNUAL MEETING - A UNIQUE GATHERING AIMED AT BRINGING THE GLOBAL CLINICAL GENOMIC COMMUNITY TOGETHER TO CREATE AN INCLUSIVE ENVIRONMENT OF COLLABORATION, EDUCATION, NETWORKING AND MENTORSHIP. WITH...

Read more

ANNUAL MEETING - A UNIQUE GATHERING AIMED AT BRINGING THE GLOBAL CLINICAL GENOMIC COMMUNITY TOGETHER TO CREATE AN INCLUSIVE ENVIRONMENT OF COLLABORATION, EDUCATION, NETWORKING AND MENTORSHIP. WITH THE CONTINUING INTER-DISPLINARY PARTNERSHIPS BETWEEN CLINICAL GENOMICISTS (CYTOGENETIC & MOLECULAR), BIOINFORMATICIANS, GENOMIC VARIANT SCIENTISTS, LABORATORY DIRECTORS, RESEARCH SCIENTISTS, PATHOLOGISTS AND ONCOLOGISTS. CGC IS COMMITTED TO PLAYING AN ESSENTIAL ROLE IN TRANSLATING SCIENTIFIC DISCOVERIES INTO THE CLINICAL DIAGONOSTICS SETTING FOR PATIENT CARE AND GUIDING THE BEST PRACTICE TO ENABLE PRECISION MEDICINE AT THE HIGHEST LEVEL. THE MEETING WILL INCLUDE INVITED SCIENTIFIC PRESENTATIONS FROM LEADING SCIENTISTS AND PROFESSIONALS, SELECTED PLATFORM AND POSTER PRESENTATIONS, ROUND TABLE DISCUSSIONS ON TOPICS, EDUCATIONAL WORKSHOPS AS WELL AS AMPLE OPPORTUNITIES TO NETWORK WITH THE INDUSTRY PARTNERS.

Program 2
Expenses: $77,054

OTHER PROGRAMS - THE CGC EARLY CAREER INITIATIVE COMMITTEE ORGANIZES AND PROMOTES INITIATIVES WITHIN CGC TO DEVELOP A COMMUNITY, FACILITATE NETWORKING, AND PROMOTE THE ENGAGEMENT OF EARLY CAREER...

Read more

OTHER PROGRAMS - THE CGC EARLY CAREER INITIATIVE COMMITTEE ORGANIZES AND PROMOTES INITIATIVES WITHIN CGC TO DEVELOP A COMMUNITY, FACILITATE NETWORKING, AND PROMOTE THE ENGAGEMENT OF EARLY CAREER MEMBERS. THE GOALS OF THE CGC EARLY CAREER COMMITTEE IS TO DEVELOP A COMMUNITY AMONG EARLY CAREER MEMBERS OF THE CGC AND PROVIDE RESOURCES INCLUDING NETWORKING OPPORTUNITIES, MENTORSHIP, BOARD EXAM PREPARATION, JOB SEARCH ADVICE, AND SOCIAL EVENTS. THE EARLY CAREER INITIATIVE COMMITTEE LIAISES WITH OTHER CGC COMMITTEES, INCLUDING THE EDUCATION, MEMBERSHIP, PROGRAM, AND COMMUNICATIONS, IN ORDER TO FURTHER THE INTERESTS OF EARLY CAREER MEMBERS. IN ADDITION, CGC HAS WEBINARS SERIES THAT FOCUSES ON TOPICS OF HIGH INTEREST FOR CGC MEMBERS AND ATTENDEES OF THE CGC ANNUAL MEETING, INCLUDING IMPLEMENTATION OF NEW TECHNOLOGIESIN CLINICAL GENOMIC TESTING, STANDARDS AND RESOURCES FOR INTERPRETATION OF SEQUENCE AND COPY NUMBER VARIANTS, GREMLINE PREDISPOSTIONS TO CANCER, AND NOVEL APPROACHES FOR DETECTION OF STRUCTURAL VARIANTS IN CONSTITUTIONAL AND CANCER SAMPLES.

Program 3
Expenses: $9,174

COMPENDIUM OF CANCER GENOME ABERRATIONS - CCGA IS A COLLABORATIVE PROJECT TO DOCUMENT GENOMIC ABERRATIONS IN CANCER BASED ON THE WHO CLASSIFICATION STRUCTURE AS AN EDUCATIONAL RESOURCE FOR DAY-TO-DAY...

Read more

COMPENDIUM OF CANCER GENOME ABERRATIONS - CCGA IS A COLLABORATIVE PROJECT TO DOCUMENT GENOMIC ABERRATIONS IN CANCER BASED ON THE WHO CLASSIFICATION STRUCTURE AS AN EDUCATIONAL RESOURCE FOR DAY-TO-DAY USE IN CLINICAL CASE INTERPRETATION. HOSTED ON A WIKI PLATFORM, THE CCGA IS DESIGNED TO PROVIDE UP-TO-DATE AND INTEGRATIVE CONTENT, HIGHLIGHTING ACTIONABLE AND DIAGNOSTICALLY-IMPORTANT FEATURES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $15,098
Program Service Revenue $477,467
Investment Income $19,253
Other Revenue $0
TOTAL REVENUE $511,818

Expense Breakdown

Grants Paid $0
Salaries & Benefits $0
Fundraising Expenses $11,873
Program Expenses $433,276
Other Expenses $498,411
TOTAL EXPENSES $498,411

Year-over-Year Comparison

2025 2024 Change
Revenue $511,818 $436,621 +0.2%
Expenses $498,411 $469,290 +0.1%
Net Income $13,407 $-32,669 -1.4%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
11
Independent Members
11
Employees
N/A
Volunteers
127

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
5
$0
Total Directors
13
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
N/A BOARD MEMBER 0.50
Director
$0 $0 $0
N/A BOARD MEMBER 0.50
Director
$0 $0 $0
N/A PRESIDENT - 1.00
Officer Director
$0 $0 $0
N/A TREASURER 1.00
Officer Director
$0 $0 $0
ANGELA LAGER PHD FACMG SECRETARY 1.00
Officer Director
$0 $0 $0
N/A PRESIDENT 1.00
Officer Director
$0 $0 $0
N/A PAST - PRESI 1.00
Officer Director
$0 $0 $0
N/A BOARD MEMBER 0.50
Director
$0 $0 $0
MEGAN FORREST PHD JUNIOR BOARD 0.50
Director
$0 $0 $0
WESLEY GOAR PHD JUNIOR BOARD 0.50
Director
$0 $0 $0
N/A BOARD MEMBER 0.50
Director
$0 $0 $0
N/A BOARD MEMBER 0.50
Director
$0 $0 $0
N/A BOARD MEMBER 0.50
Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2025 $511,818 $498,411 $571,996 $13,407
2024 No data No data No data No data
2023 $441,040 $446,547 $580,120 $-5,507
2022 $471,897 $380,318 $534,562 $91,579
2021 $289,070 $180,642 $470,210 $108,428
2020 $155,534 $145,205 $361,835 $10,329
2019 $327,435 $308,911 $301,707 $18,524
2019 $327,435 $308,911 $301,707 $18,524
2018 $288,811 $258,884 $283,183 $29,927
Explore More Nonprofits
Top 100 Nonprofits in North Carolina Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare CANCER GENOMICS CONSORTIUM with other nonprofits in North Carolina and across the country.